NASDAQ:NTLA

Intellia Therapeutics Stock Forecast

etoro logo Buy NTLA
*Your capital is at risk
$15.20
+0.650 (+4.47%)
At Close: Jun 17, 2026
AI Analysis AI Analysis of NTLA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NTLA to Watchlist?
Some Reasons Why To Add NTLA:
  • +65.0% YTD performance
  • Highly efficient cash conversion (100% FCF/OCF ratio)
  • Trading above its 200-day moving average
PDF

Volatile ride for Intellia Therapeutics Inc stock price on Wednesday moving between $14.43 and $16.73
(Updated on Jun 17, 2026)

Buy or Hold candidate since Jun 15, 2026 Gain 1.88%

The Intellia Therapeutics Inc stock price gained 4.47% on the last trading day (Wednesday, 17th Jun 2026), rising from $14.55 to $15.20. During the last trading day the stock fluctuated 15.94% from a day low at $14.43 to a day high of $16.73. The price has fallen in 6 of the last 10 days but is still up by 16.74% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 million more shares were traded than the day before. In total, 12 million shares were bought and sold for approximately $188.74 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Intellia Therapeutics Inc stock with a 90% probability to be traded between $11.96 and $16.59 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

NTLA Signals & Forecast

Mostly positive signals in the chart today. The Intellia Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.46 and $13.40. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 27.30%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Intellia Therapeutics Inc stock

Intellia Therapeutics Inc finds support from accumulated volume at $14.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.30 between high and low, or 15.94%. For the last week, the stock has had daily average volatility of 11.52%.

Our recommended stop-loss: $14.31 (-5.84%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 20 days ago.)

Trading Expectations (NTLA) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Intellia Therapeutics Inc to open at $15.45, and during the day (based on 14 day Average True Range), to move between $14.55 and $15.85, which gives a possible trading interval of +/-$1.31 (+/-8.97%) up or down from last closing price. If Intellia Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 8.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.31 (0.72%) than the support at $14.92 (1.84%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Intellia Therapeutics Inc stock A Buy?

Intellia Therapeutics Inc holds several positive signals and is considered to be a good choice at current levels. We expect the Intellia Therapeutics Inc stock to perform great in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.

Current score: 6.612 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 18, 2026 - $15.45 ( 1.67%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NTLA Performance

Trading levels for NTLA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 17.75 16.80%
R2 16.87 11.02%
R1 16.33 7.45%
Price 15.20
S1 14.57 -4.11%
S2 14.03 -7.68%
S3 13.15 -13.46%

Accumulated Volume Support & Resistance Levels

Level Price
R3 16.57 9.01%
R2 15.87 4.41%
R1 15.31 0.724%
Price 15.20
S1 14.92 -1.84%
S2 13.04 -14.21%
S3 12.45 -18.13%

FAQ

What is the symbol for Intellia Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Intellia Therapeutics Inc is NTLA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Intellia Therapeutics Inc Stock?
Intellia Therapeutics Inc holds several positive signals and is considered to be a good choice at current levels. We expect the Intellia Therapeutics Inc stock to perform great in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.

How to buy Intellia Therapeutics Inc Stock?
Intellia Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Intellia Therapeutics Inc Stock.

What's the current price of Intellia Therapeutics Inc Stock?
As of the end of day on the Jun 17, 2026, the price of an Intellia Therapeutics Inc (NTLA) share was $15.20.

What is the 52-week high and low for Intellia Therapeutics Inc Stock?
The 52-week high for Intellia Therapeutics Inc Stock is $28.24 and the 52-week low is $7.95.

What is the market capitalization of Intellia Therapeutics Inc Stock?
As of the Jun 17, 2026, the market capitalization of Intellia Therapeutics Inc is 1.706B.

When is the next earnings date for Intellia Therapeutics Inc?
The upcoming earnings date for Intellia Therapeutics Inc is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT INTELLIA THERAPEUTICS INC
Intellia Therapeutics
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE